Clinical trials in Torun – page 2

251 clinical trials in Torun, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Torun at a glance

251

clinical trials

Research sites2

Quick filters

251 trials in Torun

Open in trial search

Colitis ulcerative

Recruiting

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Investigational

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Colitis ulcerative

Recruiting

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Palmoplantar pustulosis

Recruiting

A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

Registered drug

A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Bimekizumab
Sponsor:UCB Biopharma

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Zilebesiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Vitiligo+2

Recruiting

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Povorcitinib
Sponsor:Incyte Corp.

Contact Research Centre

Arteriosclerosis

Recruiting

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Cardiac failure

Recruiting

Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

Investigational

Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:PF-07328948
Sponsor:Pfizer Inc.

Contact Research Centre

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Tulisokibart
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Generalised anxiety disorder

Recruiting

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ITI-1284
Sponsor:Intra-Cellular Therapies Inc.

Contact Research Centre

Acute myocardial infarction

Recruiting

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo

Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Colchicine
Sponsor:Medical University Of Graz

Contact Research Centre

Psoriatic arthropathy

Recruiting

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Apremilast
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:RO7790121
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Torun

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical research focusing on vaccine development for various infectious diseases, including studies on chickenpox, meningococcal, and pneumococcal vaccines. Trials evaluate immune responses in children and toddlers.

Varicella vaccine studies
Meningococcal ACYW research
Pneumococcal conjugate vaccines

These studies aim to enhance protection against common childhood infections through innovative immunization strategies.

02 Autoimmune Conditions

Extensive research into treatments for inflammatory disorders, with particular focus on novel therapies for conditions affecting joints and skin.

Psoriatic Arthritis treatments
Ulcerative Colitis therapies
Atopic Dermatitis solutions

Clinical trials are evaluating new biological and small molecule treatments to improve patient outcomes.

03 Oncology and Hematology

Advanced research in blood cancers and related conditions, focusing on innovative therapeutic approaches.

Acute Myeloid Leukemia treatments
Chronic Lymphocytic Leukemia therapies
Prostate Cancer interventions

Studies evaluate combination therapies and novel compounds for improved treatment outcomes.

04 Chronic Disease Management

Research targeting long-term conditions affecting quality of life, including cardiovascular and joint disorders.

Heart Failure prevention
Osteoarthritis treatments
IgA Nephropathy studies

Trials focus on developing therapeutic solutions for chronic condition management.

Back to Poland All countries